PTC Therapeutics, Inc.
PTCT· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2014 | Q4 2013 | Q4 2012 |
|---|---|---|---|
| Revenue | $12.66M | $4.41M | $6.64M |
| Net Income | -$27.27M | -$17.89M | -$6.27M |
| EPS Diluted | -$0.84 | -$0.75 | -$1,380.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR